Lindbrook Capital’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$9.68K Buy
738
+89
+14% +$1.32K ﹤0.01% 1663
2024
Q4
$8.72K Sell
649
-156
-19% -$2.51K ﹤0.01% 1718
2024
Q3
$17.1K Sell
805
-412
-34% -$7.42K ﹤0.01% 1382
2024
Q2
$19.3K Buy
1,217
+91
+8% +$1.67K ﹤0.01% 1263
2024
Q1
$16.7K Buy
1,126
+3
+0.3% +$41 ﹤0.01% 1304
2023
Q4
$10.3K Hold
1,123
﹤0.01% 1537
2023
Q3
$6.25K Hold
1,123
﹤0.01% 1666
2023
Q2
$9.05K Hold
1,123
﹤0.01% 1524
2023
Q1
$7.34K Hold
1,123
﹤0.01% 1650
2022
Q4
$2.76K Buy
1,123
+868
+340% +$2.71K ﹤0.01% 2095
2022
Q3
$1K Buy
+255
New +$1.49K ﹤0.01% 2438

Other funds holding OSCR

Lindbrook Capital's OSCR Position: Q1 2025 in Review

Lindbrook Capital increased its Oscar Health (OSCR) stake by 14% in Q1 2025, buying an estimated $1.32K and bringing the position to 738 shares worth $9.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

Lindbrook Capital first reported a position in OSCR in Q3 2022 and has held it in 11 quarters since. The position peaked at $19.3K in Q2 2024. 292 funds tracked by Wall St. Rank hold OSCR as of Q1 2025.

  • Lindbrook Capital held 738 shares of Oscar Health worth $9.68K as of Q1 2025.
  • Lindbrook Capital bought 89 Oscar Health shares in Q1 2025, an estimated $1.32K.
  • Oscar Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1663 holding.
  • Lindbrook Capital first reported a position in Oscar Health in Q3 2022 and has held it in 11 quarters since.
  • Lindbrook Capital's Oscar Health position peaked at $19.3K in Q2 2024.
  • 292 funds tracked by Wall St. Rank held Oscar Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.